Home
Browse
Search
Statistics
About
Usage
PMID: 10506575
Loo TW, Clarke DM
The human multidrug resistance P-glycoprotein is inactive when its maturation is inhibited: potential for a role in cancer chemotherapy.
FASEB J. 1999 Oct;13(13):1724-32.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
42
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 10506575:42:76
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 10506575:42:59
status:
NEW
view ABCB1 p.Leu332Cys details
The Cys-less mutant was also modified to contain mutations
L332C
in TM6 and
L975C
in TM12 (27).
Login to comment
64
ABCB1 p.Tyr710Ala
X
ABCB1 p.Tyr710Ala 10506575:64:79
status:
NEW
view ABCB1 p.Tyr710Ala details
ABCB1 p.Gly269Val
X
ABCB1 p.Gly269Val 10506575:64:68
status:
NEW
view ABCB1 p.Gly269Val details
ABCB1 p.Gly268Val
X
ABCB1 p.Gly268Val 10506575:64:61
status:
NEW
view ABCB1 p.Gly268Val details
Accordingly, the histidine-tagged 150 kDa protein of mutants
G268V
,
G269V
, and
Y710A
were isolated (Fig. 1, lanes 1, 3, and 5).
Login to comment
66
ABCB1 p.Tyr710Ala
X
ABCB1 p.Tyr710Ala 10506575:66:52
status:
NEW
view ABCB1 p.Tyr710Ala details
ABCB1 p.Gly269Val
X
ABCB1 p.Gly269Val 10506575:66:41
status:
NEW
view ABCB1 p.Gly269Val details
ABCB1 p.Gly268Val
X
ABCB1 p.Gly268Val 10506575:66:34
status:
NEW
view ABCB1 p.Gly268Val details
To convert the processing mutants
G268V
,
G269V
, and
Y710A
to the mature enzyme, the mutants were synthesized in the presence of 10 M cyclosporin A to induce maturation (19).
Login to comment
72
ABCB1 p.Tyr710Ala
X
ABCB1 p.Tyr710Ala 10506575:72:28
status:
NEW
view ABCB1 p.Tyr710Ala details
The mature enzyme of mutant
Y710A
had activities that were similar to wild-type P-gp.
Login to comment
73
ABCB1 p.Gly269Val
X
ABCB1 p.Gly269Val 10506575:73:68
status:
NEW
view ABCB1 p.Gly269Val details
ABCB1 p.Gly268Val
X
ABCB1 p.Gly268Val 10506575:73:58
status:
NEW
view ABCB1 p.Gly268Val details
As reported previously (19), the mature enzyme of mutants
G268V
and
G269V
had ϳ50 to 75% of the activity of wild-type P-gp.
Login to comment
76
ABCB1 p.Tyr710Ala
X
ABCB1 p.Tyr710Ala 10506575:76:169
status:
NEW
view ABCB1 p.Tyr710Ala details
ABCB1 p.Gly269Val
X
ABCB1 p.Gly269Val 10506575:76:158
status:
NEW
view ABCB1 p.Gly269Val details
ABCB1 p.Gly268Val
X
ABCB1 p.Gly268Val 10506575:76:151
status:
NEW
view ABCB1 p.Gly268Val details
ATPase activity of P-gp that is prevented from undergoing maturation It was possible that the 150 kDa core-glycosylated P-gp of the processing mutants
G268V
,
G269V
, and
Y710A
were inactive because the point mutations inherently caused misfolding of the protein and subsequent retention in the endoplasmic reticulum.
Login to comment
79
ABCB1 p.Arg113Ala
X
ABCB1 p.Arg113Ala 10506575:79:47
status:
NEW
view ABCB1 p.Arg113Ala details
A histidine-tagged Cys-less P-gp containing an
R113A
mutation and grown in the presence of 2 M MG-132 was assayed for drug-stimulated ATPase activity.
Login to comment
84
ABCB1 p.Tyr710Ala
X
ABCB1 p.Tyr710Ala 10506575:84:116
status:
NEW
view ABCB1 p.Tyr710Ala details
ABCB1 p.Gly269Val
X
ABCB1 p.Gly269Val 10506575:84:105
status:
NEW
view ABCB1 p.Gly269Val details
ABCB1 p.Gly268Val
X
ABCB1 p.Gly268Val 10506575:84:98
status:
NEW
view ABCB1 p.Gly268Val details
Equivalent amounts of histidine-tagged mature and core-glycosylated P-gp of wild-type and mutants
G268V
,
G269V
, and
Y710A
, isolated by nickel-chelate chromatography, were reconstituted with lipid and assayed for verapamil- (1 mM) and vinblastine- (0.05 mM) stimulated ATPase activities.
Login to comment
88
ABCB1 p.Tyr710Ala
X
ABCB1 p.Tyr710Ala 10506575:88:70
status:
NEW
view ABCB1 p.Tyr710Ala details
ABCB1 p.Gly269Val
X
ABCB1 p.Gly269Val 10506575:88:61
status:
NEW
view ABCB1 p.Gly269Val details
ABCB1 p.Gly268Val
X
ABCB1 p.Gly268Val 10506575:88:54
status:
NEW
view ABCB1 p.Gly268Val details
HEK293 cells expressing histidine-tagged P-gp mutants
G268V
,
G269V
or
Y710A
were incubated with (ϩ) or without (-) 10 M cyclosporin A (cyclo) for 24 h. The cells were harvested and solubilized with n-dodecyl-beta-D-maltoside and the cell extracts were subjected to nickel-chelate chromatography with 20 mM imidazole in the wash buffers.
Login to comment
92
ABCB1 p.Arg113Ala
X
ABCB1 p.Arg113Ala 10506575:92:4
status:
NEW
view ABCB1 p.Arg113Ala details
The
R113A
mutation was included since it stabilizes P-gp against proteolytic digestion during biosynthesis, and it resulted in increased yield of enzyme (23).
Login to comment
93
ABCB1 p.Arg113Ala
X
ABCB1 p.Arg113Ala 10506575:93:54
status:
NEW
view ABCB1 p.Arg113Ala details
Figure 3 shows that the major product of the Cys-less(
R113A
) mutant in the presence of increasing concentrations of MG-132 was the 150 kDa core-glycosylated intermediate.
Login to comment
96
ABCB1 p.Arg113Ala
X
ABCB1 p.Arg113Ala 10506575:96:43
status:
NEW
view ABCB1 p.Arg113Ala details
Accordingly, the histidine-tagged Cys-less(
R113A
) P-gp grown with or without 2 M MG-132 was isolated by nickel-chelate chromatography.
Login to comment
97
ABCB1 p.Arg113Ala
X
ABCB1 p.Arg113Ala 10506575:97:69
status:
NEW
view ABCB1 p.Arg113Ala details
As shown in Fig. 4A (lane 4), the 150 kDa core glycosylated Cys-less(
R113A
) P-gp could be recovered by nickel-chelate chromatography when the mutant was grown with MG-132.
Login to comment
99
ABCB1 p.Arg113Ala
X
ABCB1 p.Arg113Ala 10506575:99:44
status:
NEW
view ABCB1 p.Arg113Ala details
Equivalent amounts of the isolated Cys-less(
R113A
) P-gps were reconstituted with lipid and assayed for drug-stimulated ATPase activity.
Login to comment
108
ABCB1 p.Arg113Ala
X
ABCB1 p.Arg113Ala 10506575:108:68
status:
NEW
view ABCB1 p.Arg113Ala details
HEK293 cells were transfected with Cys-less P-gp cDNA containing an
R113A
mutation.
Login to comment
112
ABCB1 p.Arg113Ala
X
ABCB1 p.Arg113Ala 10506575:112:182
status:
NEW
view ABCB1 p.Arg113Ala details
Drug-stimulated ATPase activity of P-gp after expression in the presence or absence of MG-132. HEK293 cells were transfected with pMT21 vector (control) or histidine-tagged Cys-less(
R113A
) P-gp cDNA (P-gp).
Login to comment
120
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 10506575:120:49
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 10506575:120:39
status:
NEW
view ABCB1 p.Leu332Cys details
Cys-less P-gp containing the mutations
L332C
and
L975C
was expressed with or without MG-132 and cross-linked in the presence or absence of Mg⅐ATP.
Login to comment
121
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 10506575:121:62
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 10506575:121:56
status:
NEW
view ABCB1 p.Leu332Cys details
Figure 5 shows that ATP induces cross-linking in mutant
L332C
/
L975C
when expressed in the absence of MG-132.
Login to comment
123
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 10506575:123:79
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 10506575:123:73
status:
NEW
view ABCB1 p.Leu332Cys details
In the presence of MG-132, however, the 150 kDa core-glycosylated mutant
L332C
/
L975C
was not cross-linked by oxidant in the absence or presence of ATP (Fig. 5, lanes 6 and 8).
Login to comment
139
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 10506575:139:82
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 10506575:139:76
status:
NEW
view ABCB1 p.Leu332Cys details
HEK 293 cells were transfected with Cys-less P-gp cDNA containing mutations
L332C
/
L975C
and then incubated with (ϩMG-132) or without (-MG-132) MG-132 for 24 h. Membranes were then prepared and treated with (ϩ) or without (-) copper phenanthrolene (CuPhen) for 5 min at 37°C in the presence (ϩATP) or absence (-ATP) of 10 mM ATP.
Login to comment
145
ABCB1 p.Arg113Ala
X
ABCB1 p.Arg113Ala 10506575:145:62
status:
NEW
view ABCB1 p.Arg113Ala details
Membranes were prepared from HEK293 cells expressing Cys-less(
R113A
) P-gp that were grown with or without MG-132.
Login to comment
170
ABCB1 p.Arg113Ala
X
ABCB1 p.Arg113Ala 10506575:170:136
status:
NEW
view ABCB1 p.Arg113Ala details
Protease sensitivity of P-gp after expression in the presence or absence of MG-132. HEK293 cells expressing A52-epitope-tagged Cys-less(
R113A
) P-gp were treated with (ϩ) or without (-) 2 M MG-132 for 24 h. Membranes were then prepared and treated with various concentrations of TPCK-trypsin.
Login to comment
189
ABCB1 p.Gly341Cys
X
ABCB1 p.Gly341Cys 10506575:189:23
status:
NEW
view ABCB1 p.Gly341Cys details
ABCB1 p.Gln347Cys
X
ABCB1 p.Gln347Cys 10506575:189:33
status:
NEW
view ABCB1 p.Gln347Cys details
Some mutations such as
G341C
and
Q347C
(23, 46) expose a proteolytic site in the first extracellular loop that result in degradation of the protein during or immediately after synthesis.
Login to comment
196
ABCB1 p.Gly268Val
X
ABCB1 p.Gly268Val 10506575:196:227
status:
NEW
view ABCB1 p.Gly268Val details
Potential strategies would be to identify a pharmacological agent(s) that causes exposure of hypersensitive-protease sites such as R113 (Fig. 8, step 1), that can induce the same alterations as in the processing mutants (e.g.,
G268V
, Fig. 8, step 2), or that blocks protein folding steps as seen with protease inhibitors (Fig. 8, step 3).
Login to comment
205
ABCB1 p.Gly341Cys
X
ABCB1 p.Gly341Cys 10506575:205:34
status:
NEW
view ABCB1 p.Gly341Cys details
The presence of mutations such as
G341C
(1); processing mutations (2); or the presence of proteasome inhibitors, such as MG-132 (3), prevent maturation of P-gp and the P-gps are rapidly degraded.
Login to comment